Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2006
12/21/2006WO2006134496A2 Homeologous recombination in msh2 inactivated plants or cells thereof
12/21/2006WO2006134390A2 Method for diagnosing neurodegenerative disease
12/21/2006WO2006134376A2 Flag free chemical capture detection
12/21/2006WO2006134349A1 Classification method
12/21/2006WO2006134154A2 Enpp1 (pc-1) gene haplotype associated with the risk of obesity and type 2 diabetes and their applications
12/21/2006WO2006134128A2 Diagnostic and therapeutic target adarb2 proteins for neurodegenerative diseases
12/21/2006WO2006134056A1 Process for the identification of novel enzyme interacting compounds
12/21/2006WO2006133955A1 Adamts13-comprising compositions having thrombolytic activity
12/21/2006WO2006133931A2 Identification of jak/stat pathway modulating genes by genome wide rnai screening
12/21/2006WO2006133879A2 Vaccines for immunization against helicobacter
12/21/2006WO2006133878A2 Methods and devices for controlling the impact of short circuit faults on co-planar electrochemical sensors
12/21/2006WO2006133842A1 Impdh2 snp associated with acute rejection
12/21/2006WO2006133841A1 MDRl SNP IN ACUTE RETECTION
12/21/2006WO2006133840A1 Il10 snp associated with acute rejection
12/21/2006WO2006133701A2 Pcr diagnostics of dermatophytes and other pathogenic fungi
12/21/2006WO2006133568A1 Virtual mass spectrometry
12/21/2006WO2006133555A1 Psychotropic drug screening device based on long-term photoconductive stimulation of neurons
12/21/2006WO2006133508A1 Methods of treatment, and diagnosis of epilepsy by detecting mutations in the scn1a gene
12/21/2006WO2006119439A9 Compositions and methods for the analysis of degraded nucleic acids
12/21/2006WO2006116127A3 Compositions for use in identification of bacteria
12/21/2006WO2006116016A3 Molecular determinants of egfr kinase inhibitor response in glioblastoma
12/21/2006WO2006110585A3 Cancer-related genes (prlr)
12/21/2006WO2006107198A3 Production of unconjugated oligosaccharides by pathogens
12/21/2006WO2006103094A3 Method for treating a sample that contains biomolecules
12/21/2006WO2006099579A3 Compositions and methods for clonal amplification and analysis of polynucleotides
12/21/2006WO2006097748A3 Peptide stabilizer compounds and screening method
12/21/2006WO2006089268A8 Gene and cognate protein profiles and methods to determine connective tissue markers in normal and pathologic conditions
12/21/2006WO2006084130A3 Ultra-sensitive detection systems using multidimension signals
12/21/2006WO2006056028A3 Autism genes and regulated secretion
12/21/2006WO2006053771A3 Agonists of bitter taste receptors and uses thereof
12/21/2006WO2006052823A3 Biomarkers for prostate cancer metastasis
12/21/2006WO2006042112A3 Aptamer regulated nucleic acids and uses thereof
12/21/2006WO2006022895A3 Platelet biomarkers for cancer
12/21/2006WO2006015195A8 Methods for determining the potency, specificity, and toxicity of hematopoietic prostaglandin d2 synthase
12/21/2006WO2005124351A8 A sensitive antibody-based method for detecting cryptosporidium parvum oocysts in water
12/21/2006WO2005111613A3 Methods of identifying apoptotic cells
12/21/2006WO2005104810A3 Novel therapeutic targets in cancer
12/21/2006WO2005103281A9 Platelet biomarkers for the detection of disease
12/21/2006WO2005094306A3 Identification of genes or polypeptides the expression of which correlates to fertility, ovarian function and/or fetal/newborn viability
12/21/2006WO2005086794A3 Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor
12/21/2006WO2005062967A3 Novel anti-il 13 antibodies and uses thereof
12/21/2006WO2005040339A3 Aptamers to human epidermal growth factor receptor-3
12/21/2006WO2004092191A3 Polymeric oligonucleotide prodrugs
12/21/2006WO2004078922A3 Modulation of growth hormone receptor expression and insulin-like growth factor expression
12/21/2006WO2003054144A3 Human ras interacting protein
12/21/2006US20060288452 Expression vector comprising nucleotide sequences coding regulatory sequences associated with ADP-glucose pyrophosphorlyase gene for use as tool in controlled transcription of heterologous protein in plant storage roots
12/21/2006US20060288444 Soybean polymorphisms and methods of genotyping
12/21/2006US20060288434 Inhibiting angiogenesis in a mammal by administering an antibody which specifically binds to EphriniB2 or EphB4; cardiovascular disorders
12/21/2006US20060288433 Selecting a domestic animal for having desired genotypic properties bytesting the animal for the presence of a parentally imprinted quantitative trait locus; particularly selecting properties related to muscle mass, fat deposition, sow prolificacy, and/or sow longevity in pigs
12/21/2006US20060288431 Marker for undifferentiated state of cell and composition and method for separation and preparation of stem cells
12/21/2006US20060287513 Compositions and methods for the therapy and diagnosis of breast cancer
12/21/2006US20060287503 Analyzing fusion protein expression; biological screening
12/21/2006US20060287502 C3b/C4b complement receptor-like molecules and uses thereof
12/21/2006US20060287358 Treatment of CNS disorders associated with mutations in genes encoding lysosomal enzymes
12/21/2006US20060287276 administering methyl alpha manno-oligosaccharide and proanthocyanidins to treat enteric disorders selected from gastroenteritis, ulcerative colitis, diarrhoeal disease caused by pathogenic bacteria adhesion to mammalian intestinal epithelial cells
12/21/2006US20060287272 Methods for determining specificity of RNA silencing and for genetic analysis of the silenced gene or protein
12/21/2006US20060287269 Short interfering nucleic acid hybrids and methods thereof
12/21/2006US20060287261 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
12/21/2006US20060287230 Compositions which can be used for regulating the activity of parkin
12/21/2006US20060286683 Method and testing system for analyzing and/or detecting biomolecules and/or active substances in liquid samples
12/21/2006US20060286671 Efficient generation of expression cell lines through the use of scorable homeostatic reporter genes
12/21/2006US20060286670 Transplant acceptance inducing cells of monocytic origin and their preparation and use
12/21/2006US20060286662 Medical diagnostic test strip
12/21/2006US20060286660 Biosensors having reduced haemocrit effect
12/21/2006US20060286656 Characterization of the I-SpomI endonuclease from fission yeast
12/21/2006US20060286642 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
12/21/2006US20060286630 Posh interacting proteins and related methods
12/21/2006US20060286625 Rapid enrichment for Listeria
12/21/2006US20060286624 Method for identifying selective growth inhibitors
12/21/2006US20060286623 Three dimensional object manipulating method and device
12/21/2006US20060286622 Polypeptides exhibiting PDE7 activity and their use for selecting compounds which inhibit PDE 7 enzyme activity
12/21/2006US20060286621 Extraction methods and assays for feed enzymes
12/21/2006US20060286620 Glucose analysis instrument
12/21/2006US20060286619 Device for performing analyses on biological fluids and related method
12/21/2006US20060286618 AMP Assay
12/21/2006US20060286610 Identification of ligands by selective amplification of cells transfected with receptors
12/21/2006US20060286603 Combinatorial libraries of monomer domains
12/21/2006US20060286600 High throughput one-hybrid system
12/21/2006US20060286599 Open channel solid phase extraction systems and methods
12/21/2006US20060286598 Isolated CEL II endonuclease
12/21/2006US20060286597 Aortic carboxypeptidase-like polypeptide
12/21/2006US20060286596 Method and apparatus for separating and purifying biopolymers
12/21/2006US20060286595 Independent of the patient's human papilloma virus (HPV) infection status by detecting biomarker(s) selectively overexpressed in high-grade cervical disease; kits
12/21/2006US20060286594 Detection of antidepressant induced mania
12/21/2006US20060286593 Transforming Growth Factor Alpha HI
12/21/2006US20060286592 Increased ability to convert 5-fluorocytosine prodrug to its toxic form
12/21/2006US20060286591 Methods and compositions for expressing negative-sense viral RNA in canine cells
12/21/2006US20060286590 Cis-regulatory modules
12/21/2006US20060286589 Method of screening multiple single nucleotide polymorphisms associated with susceptibility to specific disease or drug response
12/21/2006US20060286588 Genetic variants in the TCF7L2 gene as diagnostic markers for risk of type 2 diabetes mellitus
12/21/2006US20060286587 Methods for quantitative analysis of a nucleic acid amplification reaction
12/21/2006US20060286586 Method to diagnose or screen for inflammatory diseases
12/21/2006US20060286585 Methods for diagnosing epigenetic, transgenerational effects of environmental toxicants on mammalian germ-lines and treating associated diseases
12/21/2006US20060286584 Compositions and methods for the regulation of cell proliferation and apoptosis
12/21/2006US20060286583 Different nucleic acids are captured through cooperative hybridization events on different, identifiable subsets of particles or at different selected positions on a spatially addressable solid support.
12/21/2006US20060286582 Rotatable flipper at the outside of the microchip on the base holder opens and closes the input hole by flipping up in a vertically erected state or flipping down in a horizontal state; and slider slides and supports the flipper in the erected state and flips down the flipper while moving inside
12/21/2006US20060286581 Heteroconfigurational Polynucleotides and Methods of Use
12/21/2006US20060286580 amplification methods of multiple genetic targets and analysis of amplified products using microarrays
12/21/2006US20060286579 Normalization genes
12/21/2006US20060286578 Detection of 5T4 RNA in plasma and serum